| Name | Oncimmune Holdings |
|---|---|
| Epic | ONC |
| Isin | GB00BYQ94H38 |
| Index | AIM100 AIM350 |
| Industry |
| Latest share price | 15.35p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £17.16 | Debt ratio | n/a |
| Shares in issue | 74.14 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -98.08 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -8.47 | 52-week high / low | 9.58p / 29.10p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Oncimmune Holdings |
|---|---|
| Address | MediCity - D6 Building, 1 Thane Road, Nottingham, United Kingdom, NG90 6BH |
| Telephone | +44 1157 840 500 |
| Website | http://oncimmune.com |
| Director | Position |
|---|---|
| Mr Martin Gouldstone | CEO |
| Mr John Goold | Non-Executive Director |
| Mr Alistair Macdonald | Non-Executive Chairman |
| Mr Sally Waterman | Senior Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/08/23 | 31/08/22 | 31/05/21 |
| Intangible asssets and goodwill | 2.06 | 4.59 | 5.69 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 2.87 | 6.55 | 8.22 |
| Inventory / work in progress | 0.23 | 0.43 | 0.14 |
| Trade and other receivables | 1.96 | 1.34 | 2.16 |
| Cash and equivalents | 3.21 | 1.43 | 8.63 |
| Other current assets and asset held for resale | 0.16 | 0.42 | 0.2 |
| Total of all assets | 8.44 | 10.16 | 19.36 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 1.42 | 7.82 | 4.85 |
| Long term liabilities | 6.36 | 6.52 | 9.28 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 7.78 | 14.34 | 14.13 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 0.66 | -4.18 | 5.23 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.74 | 0.69 | 0.69 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -43.64 | -75.42 | -66 |
| Share premium account | 42.68 | 40.63 | 40.5 |
| Total equity | 0.66 | -4.18 | 5.23 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.92 | -6.29 | -5.55 |
| Pre-tax profit | -5.93 | -6.58 | -6.06 |